Cent Eur J Public Health 2017, 25(4):261-265 | DOI: 10.21101/cejph.a5019

Legislative Norms to Control Cannabis Use in the Light of Its Prevalence in the Czech Republic, Poland, Slovakia, and Hungary

Róbert Čecho, Tibor Baška, Viera Švihrová, Henrieta Hudečková
Department of Public Health, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovak Republic

Objectives: Cannabis control legislation ranks among key measures to prevent social-health impacts of its use. The article qualitatively analyses respective legislation in the Czech Republic, Poland, Slovakia, and Hungary (Visegrad Four, V4) considering level of decriminalisation of cannabis use in relation to current epidemiological situation.

Methods: Qualitative analysis of the cannabis control legislation in V4 countries from 1995 to 2016 focusing on criminal liability, differentiation of cannabis from other illicit substances, definition of a small amount intended for personal use, sentences for possessing and dealership of the drug.

Results: Slovakia, Hungary and Poland share similar restrictive legislative approach throughout the studied period. In the Czech Republic, the situation has been different and since 2010 cannabis has been further decriminalised: possession of defined small amount of drug not being under prosecution and milder sentences for cannabis than for other illicit psychoactive substances.

Conclusion: Although the prevalence of cannabis use among adolescents is the highest in the Czech Republic, partial decriminalisation did not show further increase. Slovakia, Hungary and Poland show different trends in epidemiological situation despite of similar legislative approach. Results indicate that beside legislation other social factors play a role and measures to change attitudes and decrease social tolerance are important.

Klíčová slova: cannabis, legislative measures, decriminalisation, substance use, Visegrad Four

Vloženo: 23. prosinec 2016; Revidováno: 14. listopad 2017; Zveřejněno: 30. prosinec 2017  Zobrazit citaci

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Čecho R, Baška T, Švihrová V, Hudečková H. Legislative Norms to Control Cannabis Use in the Light of Its Prevalence in the Czech Republic, Poland, Slovakia, and Hungary. Cent Eur J Public Health. 2017;25(4):261-265. doi: 10.21101/cejph.a5019. PubMed PMID: 29346846.
Sdílet...
Stáhnout citaci
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Zobrazit celý článek

    Reference

    1. European Monitoring Centre for Drugs and Drug Addiction. European drug report (2014): trends and developments. Luxembourg: Publications Office of the European Union; 2016.
    2. Ramström J. Adverse health consequences of cannabis use. A survey of scientific studies published up to and including the Autumn of 2003. Stockholm: National Institute of Public Health - Sweden; 2004.
    3. Joshi M, Joshi A, Bartter T. Marijuana and lung diseases. Curr Opin Pulm Med. 2014;20(2):173-9. Přejít k původnímu zdroji... Přejít na PubMed...
    4. Bachman J, O' Malley PM, Schulenberg JE, Johnston L, Freedman-Doan P, Messersmith EE. The education-drug use connection. How successes and failures in school relate to adolescent smoking, drinking, drug use, and delinquency. New York (NY): Lawrence Erlbaum Associates; 2008. Přejít k původnímu zdroji...
    5. Secades-Villa R, Garcia-Rodríguez O, Jin CJ, Wang S, Blanco C. Probability and predictors of the cannabis gateway effect: a national study. Int J Drug Policy. 2015 Feb;26(2):135-42. Přejít k původnímu zdroji... Přejít na PubMed...
    6. Fergusson DM, Boden JM, Horwood LJ. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction. 2006 Apr;101(4):556-69. Přejít k původnímu zdroji... Přejít na PubMed...
    7. European Monitoring Centre for Drugs and Drug Addiction. Cannabis legislation in Europe: An overview. Luxembourg: Publications Office of the European Union; 2017.
    8. Room R, et al. Cannabis policy: moving beyond stalemate. Oxford: Oxford University Press; 2010.
    9. Shi Y, Lenzi M, Ruopeng A. Cannabis liberalization and adolescent cannabis use: a cross - national study in 38 countries. PLoS ONE. 2015;10(11):e0143562. doi: 10.1371/journal.pone.0143562. Přejít k původnímu zdroji... Přejít na PubMed...
    10. Reinarman C, Cohen D, Kaal L. The limited relevance of drug policy: cannabis in Amsterdam and in San Francisco. Am J Public Health. 2004;94(5):836-42. Přejít k původnímu zdroji... Přejít na PubMed...
    11. Červený J, Chomynová, P, Mravčík V, van Ours JC. Cannabis decriminalization and the age of onset of cannabis use. Int J Drug Policy. 2017;43:122-9. Přejít k původnímu zdroji... Přejít na PubMed...
    12. Mravčík V. (De)criminalisation of possession of drugs for personal use - a view from the Czech Republic. Int J Drug Policy. 2015;26(7):705-7. Přejít k původnímu zdroji... Přejít na PubMed...
    13. Pardo B. Cannabis policy reforms in the Americas: a comparative analysis of Colorado, Washington, and Uruguay. Int J Drug Policy. 2014;25(4):727-35. Přejít k původnímu zdroji... Přejít na PubMed...
    14. Ter Bogt T, Schmid H, Gabhainn SN, Fotiou A, Vollebergh W. Economic and cultural correlates of cannabis use among mid-adolescents in 31 countries. Addiction. 2006 Feb;101(2):241-51. Přejít k původnímu zdroji... Přejít na PubMed...
    15. Kážmér L, Csémy L, Ružbarská I, Pavelka J, Hamřík Z, Kalman M. Trends in lifetime cannabis use among Czech school-aged children from 2002 to 2014. Cent Eur J Public Health. 2017 Jul;25 Suppl 1:S47-S50. Přejít k původnímu zdroji... Přejít na PubMed...
    16. Hibell B, Andersson B, Bjarnason T, Kokkevi A, Morgan M, Narusk A. The 1995 ESPAD report: alcohol and other drug use among students in 26 European countries. Stockholm: Swedish Council for Information on Alcohol and Other Drugs; 1997.
    17. Hibell B, Andersson B, Ahlström S, Balakireva O, Bjarnason T, Kokkevi A, et al. The 1999 ESPAD report: alcohol and other drug use among students in 30 European countries. Stockholm: Swedish Council for Information on Alcohol and Other Drugs; 2000.
    18. Hibell B, Andersson B, Bjarnason T, Ahlström S, Balakireva O, Kokkevi A, et al. The ESPAD report 2003: alcohol and other drug use among students in 35 European countries. Stockholm: Swedish Council for Information on Alcohol and Other Drugs; 2004.
    19. Hibell B, Guttormsson U, Ahlström S, Balakireva O, Bjarnason T, Kokkevi A, at al. The 2007 ESPAD report: substance use among students in 35 European countries. Stockholm: Swedish Council for Information on Alcohol and Other Drugs; 2009.
    20. Hibell B, Guttormsson U, Ahlström S, Balakireva O, Bjarnason T, Kokkevi A, at al. The 2011 ESPAD report: substance use among students in 36 European countries. Stockholm: Swedish Council for Information on Alcohol and Other Drugs; 2012.
    21. European School Survey Project on Alcohol and Other Drugs. ESPAD Report 2015: results from the European School Survey Project on Alcohol and Other Drugs. Luxembourg: Publications Office of the European Union; 2016.
    22. European legal database on drugs (ELDD) [Internet]. Lisbon: European Monitoring Centre for Drugs and Drug Addiction [cited 2016 Dec 8]. Available from: http://www.emcdda.europa.eu/eldd.
    23. Radimecký J. Rhetoric versus practice in Czech drug policy. J Drug Issues. 2007;37(1):11-44. Přejít k původnímu zdroji...
    24. Zábranský T, Miovský M, Gajdošíková H, Mravčík V. Impact analysis project of new drugs legislation: summary final report. Prague: Office of the Czech Government Secretariat of the National Drug Commission; 2001.
    25. Zeman P. Legislation and practice concerning prosecution of drug offenses in the Czech Republic. J Drug Issues. 2007;37(1):45-72. Přejít k původnímu zdroji...
    26. Act No. 140 Penal Code. Sbírka zákonů ČR. 1961 Dec 8;Part 65:465-512. (In Czech).
    27. Act No. 40 Penal Code of January 8, 2009. Sbírka zákonů ČR. 2009 Feb 9;Pt 11:354-464. (In Czech).
    28. Act No. 300 Penal Code of May 20, 2005, as amended. Zbierka zákonov SR. 2005 Jul 2;Pt 129;3002-90. (In Slovak).
    29. Act C Penal Code of 2012. Magyar Közlöny. 2012 Jul 13;Pt 92:1-122. (In Hungarian).
    30. Act No. 553 Penal Code of June 6, 1997, as amended. Dziennik ustaw RP. 1997 Aug 2;Pt 88:2677-716. (In Polish.)
    31. Grund JP, Zabransky T, Irwin KS, Heimer R. Stimulant use in Central and Eastern Europe: how recent social history shaped current drug consumption patterns. In: Pates R, Riley D, editors. Interventions for amphetamine misuse. Chichester: Blackwell Pub./Addiction Press; 2010. p. 173-203.
    32. Kokkevi A, Nic Gabhainn S, Spyropoulou M; Risk Behaviour Focus Group of the HBSC. Early initiation of cannabis use: a cross-national European perspective. J Adolesc Health. 2006 Nov;39(5):712-9. Přejít k původnímu zdroji... Přejít na PubMed...
    33. Becker GS, Murphy KM, Grossman M. The market for illegal goods: the case of drugs. J Polit Econ. 2006;114(1):38-60. Přejít k původnímu zdroji...
    34. Mravčík V, Chomynová P, Grohmannová K, Nečas V, Grolmusová L, Kiššová L, et al. Annual report: The Czech Republic - 2012 drug situation. Prague: Office of the Government of the Czech Republic; 2013.
    35. Klobucký R. Why is a restrictive drug policy promoted in Slovakia? In: 6th Olomouc Sociological Autumn Conference; 2016 Oct 19-21; Olomouc, Czech Republic. (In Slovak.)
    36. Pitel L, Madarasova Geckova A, Kolarcik P, Halama P, Reijneveld SA, van Dijk JP. Gender differences in the relationship between religiosity and health-related behaviour among adolescents. J Epidemiol Community Health. 2012 Dec;66(12):1122-8. Přejít k původnímu zdroji... Přejít na PubMed...
    37. Csete J. A balancing act: Policymaking on illicit drugs in the Czech Republic. New York: Open Society Foundations; 2012.
    38. Room R. Legalizing a market for cannabis for pleasure: Colorado, Washington, Uruguay and beyond. Addiction. 2014;109(3):345-51. Přejít k původnímu zdroji... Přejít na PubMed...
    39. Álvarez A, Gamella JF, Parra I. The legalization of cannabis derivatives in Spain: Hypothesis on a potential emerging market. Adicciones. 2017;29(3):195-206. Přejít k původnímu zdroji... Přejít na PubMed...
    40. Hopfer C. Implications of marijuana legalization for adolescent substance use. Subst Abuse. 2014;35(4):331-5. Přejít k původnímu zdroji... Přejít na PubMed...
    41. Ogrodnik M, Kopp P, Bongaerts X, Tecco JM. An economic analysis of different cannabis decriminalization scenarios. Psychiatr Danub. 2015 Sep;27 Suppl 1:S309-14. Přejít na PubMed...
    42. Csémy L, Lejčková P, Sadílek P. Substance use among Czech adolescents: an overview of trends in the international context. J Drug Issues. 2007;37(1):119-32. Přejít k původnímu zdroji...
    43. Ventura E, Wagner H, Rossi C. New indicators of health among adolescent drug users and evaluation of drug policies comparing countries. Epidemiol Biostat Public Health. 2015;12(1 Suppl 1).
    44. Kuntsche E, Simons-Morton R, Fotiou A, Ter Bogt T, Kokkevi A; Health Behavior in School-Aged Children Study. Decrease in adolescent cannabis use from 2002 to 2006 and links to evenings spent out with friends in 31 European and North America countries and regions. Arch Pediatr Adolesc Med. 2009 Feb;163(2):119-25. Přejít k původnímu zdroji... Přejít na PubMed...

    Zpět na obsah